Current decision-making in prostate cancer therapy
- PMID: 18382237
- DOI: 10.1097/MOU.0b013e3282fba5f2
Current decision-making in prostate cancer therapy
Abstract
Purpose of review: Prostate cancer continues to be the most prevalent cancer among American men. Localized prostate cancer is commonly diagnosed because of improved screening practices nationwide. Several options exist for the treatment of localized prostate cancer, and this review discusses the decision-making process facing patients diagnosed with this disease.
Recent findings: No one treatment for localized prostate cancer has proven superior to date. For this reason patients have been found to use a number of resources to make an informed decision. These include physicians, spouses, family, friends, and different media. Urologists serve as the primary and most influential physicians and play an important role in the decision-making process. Patients, however, are assuming a more active role in this process as time evolves, especially with ease of access to multiple information resources.
Summary: In deciding on a treatment for localized prostate cancer, patients must weigh the risks and benefits of each option. Urologists must provide patients with up-to-date information on these options and be aware of the different influences that surround these men during the decision-making process.
Similar articles
-
Evidence-based patient choice: a prostate cancer decision aid in plain language.BMC Med Inform Decis Mak. 2005 Jun 20;5:16. doi: 10.1186/1472-6947-5-16. BMC Med Inform Decis Mak. 2005. PMID: 15963238 Free PMC article.
-
Evaluating a decision aid for patients with localized prostate cancer in clinical practice.Urol Int. 2008;81(4):383-8. doi: 10.1159/000167833. Epub 2008 Dec 10. Urol Int. 2008. PMID: 19077396
-
Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.Oncol Nurs Forum. 2009 Jan;36(1):89-96. doi: 10.1188/09.ONF.89-96. Oncol Nurs Forum. 2009. PMID: 19136342
-
Treatment options for prostate cancer: evaluating the evidence.Am Fam Physician. 2005 May 15;71(10):1915-22. Am Fam Physician. 2005. PMID: 15926407 Review.
-
The patient's dilemma: prostate cancer treatment choices.J Urol. 2003 Mar;169(3):828-33. doi: 10.1097/01.ju.0000052056.27609.8a. J Urol. 2003. PMID: 12576794 Review.
Cited by
-
Usability evaluation of the interactive Personal Patient Profile-Prostate decision support system with African American men.J Natl Med Assoc. 2010 Apr;102(4):290-7. doi: 10.1016/s0027-9684(15)30601-5. J Natl Med Assoc. 2010. PMID: 20437736 Free PMC article.
-
Explainable ML models for a deeper insight on treatment decision for localized prostate cancer.Sci Rep. 2023 Jul 17;13(1):11532. doi: 10.1038/s41598-023-38162-1. Sci Rep. 2023. PMID: 37460568 Free PMC article.
-
Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience.J Oncol Pract. 2010 Nov;6(6):e5-e10. doi: 10.1200/JOP.2010.000071. J Oncol Pract. 2010. PMID: 21358951 Free PMC article.
-
Sources of Information for Learning and Decision-Making in Men With Localized Prostate Cancer.Am J Mens Health. 2020 Sep-Oct;14(5):1557988320945461. doi: 10.1177/1557988320945461. Am J Mens Health. 2020. PMID: 33000703 Free PMC article.
-
Helping patients with localized prostate cancer reach treatment decisions.Can Fam Physician. 2010 Feb;56(2):137-41. Can Fam Physician. 2010. PMID: 20154243 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials